FernandoNH, HurwitzHI. Targeted therapy of colorectal cancer: clinical experience with bevacizumab. Oncologist2004;9(suppl 1):11–8.
2.
GordonMS, CunninghamD.Managing patients treated with bevacizumab combination therapy. Oncology2005;69(suppl 3):25-33.
3.
HenryTD, AnnexBH, McKendallGR, . The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation2003;107:1359-65.
4.
KatohM, EgashiraK, MitsuiT, . Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol2000;32:73-83.
5.
HaraA, WadaT, FuruichiK, . Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int2006;69:1986-95.
